Answers are grounded in this paper and cite their sources.
Research on the tumor microenvironment (TME) in breast cancer (BC) has witnessed substantial advancements in recent decades, with a growing emphasis on elucidating its key cellular and molecular components as well as their dual roles in either promoting or suppressing tumor progression. These investigations have laid the foundation for innovative therapeutic strategies targeting TME dynamics. Clinically, the heterogeneity of TME has already been exploited for diagnostic purposes, while an expanding array of immunotherapies and molecularly targeted agents are being incorporated into treatment regimens for specific BC subtypes. This review systematically examines the structural and functional complexity of TME, while providing a comprehensive synthesis of its current applications in BC immunotherapy and precision medicine. These discussions are anticipated to offer novel conceptual frameworks for future research, potentially guiding the development of next-generation treatments that exploit the tumor-modulating properties of TME components through more sophisticated mechanistic approaches.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: